Keyphrases
Glioblastoma
100%
Carboplatin
100%
Paclitaxel
100%
Low-intensity Pulsed Ultrasound (LIPUS)
100%
Microbubbles
50%
Glioma
25%
Monotherapy
25%
Local Tumor Control
25%
Clinical Trials
12%
Xenograft
12%
Apoptosis
12%
Overall Survival
12%
Disease Control
12%
Survival Benefit
12%
Phase II Trial
12%
Phase I Trial
12%
Cytotoxicity
12%
DNA Damage
12%
Cell Cycle Progression
12%
Glioma Model
12%
Recurrent Glioblastoma
12%
Intracranial Xenografts
12%
Cell Cycle Arrest
12%
Human Glioma
12%
Cross-resistance
12%
Target Dose
12%
Complementarity Effect
12%
Intraoperative Testing
12%
Loewe
12%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Paclitaxel
100%
Carboplatin
100%
Neoplasm
25%
Monotherapy
25%
Phase I Trials
12%
Phase II Trials
12%
Clinical Trial
12%
Overall Survival
12%
Cross-Resistance
12%
Cytotoxicity
12%
Diseases
12%
Neuroscience
Carboplatin
100%
Paclitaxel
100%
Cytotoxicity
12%
Magnetic Resonance Imaging
12%
DNA Damage
12%
Cell Cycle Progression
12%
Cell Cycle Arrest
12%
Cell Cycle Checkpoint
12%
Programmed Cell Death
12%